National Drug File - Reference Terminology

Last uploaded: July 6, 2018
Jump to:
loading...
Preferred Name

Levodopa [Chemical/Ingredient]
Synonyms

L-Dopa

Levodopa

L-3,4-Dihydroxyphenylalanine

3-Hydroxy-L-tyrosine
ID

http://purl.bioontology.org/ontology/NDFRT/N0000006700
altLabel

L-Dopa

Levodopa

L-3,4-Dihydroxyphenylalanine

3-Hydroxy-L-tyrosine
cui

C0023570
Ingredient of

http://purl.bioontology.org/ontology/NDFRT/N0000191394

http://purl.bioontology.org/ontology/NDFRT/N0000151079

http://purl.bioontology.org/ontology/NDFRT/N0000151084

http://purl.bioontology.org/ontology/NDFRT/N0000151082

http://purl.bioontology.org/ontology/NDFRT/N0000022331

http://purl.bioontology.org/ontology/NDFRT/N0000163644

http://purl.bioontology.org/ontology/NDFRT/N0000178449

http://purl.bioontology.org/ontology/NDFRT/N0000151086

http://purl.bioontology.org/ontology/NDFRT/N0000191393

http://purl.bioontology.org/ontology/NDFRT/N0000146151

http://purl.bioontology.org/ontology/NDFRT/N0000151085

http://purl.bioontology.org/ontology/NDFRT/N0000178358

http://purl.bioontology.org/ontology/NDFRT/N0000164494

http://purl.bioontology.org/ontology/NDFRT/N0000164493

http://purl.bioontology.org/ontology/NDFRT/N0000191392

http://purl.bioontology.org/ontology/NDFRT/N0000177489

http://purl.bioontology.org/ontology/NDFRT/N0000151081

http://purl.bioontology.org/ontology/NDFRT/N0000020155

http://purl.bioontology.org/ontology/NDFRT/N0000151080

http://purl.bioontology.org/ontology/NDFRT/N0000191435

http://purl.bioontology.org/ontology/NDFRT/N0000164492

http://purl.bioontology.org/ontology/NDFRT/N0000151083

http://purl.bioontology.org/ontology/NDFRT/N0000191391

http://purl.bioontology.org/ontology/NDFRT/N0000165123

http://purl.bioontology.org/ontology/NDFRT/N0000165122

http://purl.bioontology.org/ontology/NDFRT/N0000165124
MESH DEFINITION

The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system.
MESH DUI

D007980
MeSH name

Levodopa
MESH UI

M0012434
NDFRT kind

INGREDIENT_KIND
notation

N0000006700
NUI

N0000006700
prefLabel

Levodopa [Chemical/Ingredient]
tui

T116

T123

T121
subClassOf

http://purl.bioontology.org/ontology/NDFRT/N0000007917
Add comment
Add proposal
Delete Subject Author Type Created
No notes to display
Create mapping